OPC 21268
CAS: 131631-89-5
Rif. 3D-GFA63189
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta | |
| 50mg | Prezzo su richiesta | |
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
- Acetamide, N-[3-[4-[[4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-
- N-[3-(4-{[4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)piperidin-1-yl]carbonyl}phenoxy)propyl]acetamide
- N-[3-[4-[4-(2-Oxo-1,2,3,4-tetrahydro-1-quinolinyl)piperidin-1-ylcarbonyl]phenoxy]propyl]acetamide
- N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]acetamide
- Opc-21268
OPC 21268 is a drug used to treat chronic congestive heart failure. The drug works by increasing the concentration of cytosolic Ca2+ in cardiac myocytes, which leads to increased contractility and vasopressin secretion. OPC 21268 has been shown to be effective in experimental models of congestive heart failure. OPC 21268 causes vasoconstriction in the renal medulla, thereby increasing the glomerular filtration rate and reducing edema. This drug also has an effect on gland cells, leading to an increase in transcription-polymerase chain reaction activity and cellular proliferation.
Proprietà chimiche
Richiesta tecnica su: 3D-GFA63189 OPC 21268
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
